Publication:
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine

Thumbnail Image

Date

2012

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier BV
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Zhang, Xue-Qing, Xiaoyang Xu, Nicolas Bertrand, Eric Pridgen, Archana Swami, and Omid C. Farokhzad. 2012. Interactions of Nanomaterials and Biological Systems: Implications to Personalized Nanomedicine. Advanced Drug Delivery Reviews 64 (13) (October): 1363–1384. doi:10.1016/j.addr.2012.08.005.

Research Data

Abstract

The application of nanotechnology to personalized medicine provides an unprecedented opportunity to improve the treatment of many diseases. Nanomaterials offer several advantages as therapeutic and diagnostic tools due to design flexibility, small sizes, large surface-to-volume ratio, and ease of surface modification with multivalent ligands to increase avidity for target molecules. Nanomaterials can be engineered to interact with specific biological components, allowing them to benefit from the insights provided by personalized medicine techniques. To tailor these interactions, a comprehensive knowledge of how nanomaterials interact with biological systems is critical. Herein, we discuss how the interactions of nanomaterials with biological systems can guide their design for diagnostic, imaging and drug delivery purposes. A general overview of nanomaterials under investigation is provided with an emphasis on systems that have reached clinical trials. Finally, considerations for the development of personalized nanomedicines are summarized such as the potential toxicity, scientific and technical challenges in fabricating them, and regulatory and ethical issues raised by the utilization of nanomaterials.

Description

Keywords

Nanomaterials, Nanoparticles, Targeted Delivery, Personalized Nanomedicine, Nanotechnology, Molecular Diagnostic, in vivo Imaging, Protein Binding, Receptor-Mediated Endocytosis

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories